Blog
Daniel Alain Acquires Stake in Applied Biology Inc.
Newport Beach, 04, 2020 — Daniel Alain, Inc. has acquired a stake in Applied Biology, a biotechnology company conducting scientific
research in alopecia and androgen mediated diseases. CEO, Daniel Hafid, commented, “We are seeking to offer women a 360 solution for hair loss.”
This acquisition will allow it to develop tests to identify women who are likely to develop hair loss prior to presenting clinical symptoms as well as a diagnostic test to identify non-responders to topical minoxidil. Female Pattern Hair Loss (FPHL) affects up to 50% of women by the age of 65, but only a minority of patients respond to topical minoxidil.
Founded in 2004, Daniel Alain is a hair loss and hair enhancement company. Its portfolio includes FOLLEA Luxury Wigs and Hair Enhancements and INTACT Anti Hair Shedding Treatment.
Related Posts
Autumn Shedding
The Thinning Hair Attachment Safety Guide
When Hair Is Not Enough
New Hope for Teens Facing Sudden Hair Loss
What If You Could See the Future You?
Independent Hair News Source Joins Telehealth Brand
Cambridge Researchers Harnessing Cellular Energy
Hair, Health, and Hope
Hair Loss Tops Global Beauty Concerns
Stem Cells Discovery Sheds Light on Hair Regeneration
Leqselvi – FDA Approved for Severe Alopecia Areata
New Study Says Weight-Loss Drugs Cause Hair Thinning
One thought on “Daniel Alain Acquires Stake in Applied Biology Inc.”
Click here to cancel reply.
You must be logged in to post a comment.
Nice.